首页> Cancer Immunology and Immunotherapy: Other Biological Response Modifications> Response to the letter to the editors by Ottaiano et al.: "Cetuximab-dependent ADCC in cancer: Dream or reality?"

Response to the letter to the editors by Ottaiano et al.: "Cetuximab-dependent ADCC in cancer: Dream or reality?"

导出原文传递

翻译打印收藏纠错

第一作者： Ferris,R.L.

作者： Ferris,R.L. ^[1] ; Ferrone,S. ^[2]

作者单位： Cancer Immunology Program, University of Pittsburgh Cancer Institute, Pittsburgh, United States ^[1] Division of Head and Neck Surgery, Departments of Otolaryngology and of Immunology, University of ^[2]

发布时间 2014-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer Immunology and Immunotherapy

2010年59卷10期

1609-1610页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer Immunology and Immunotherapy

2010年59卷10期

1609-1610页

检索历史清除

Response to the letter to the editors by Ottaiano et al.: "Cetuximab-dependent ADCC in cancer: Dream or reality?"

Cancer Immunology and Immunotherapy

相似文献

同项目论文

Cancer Immunology and Immunotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Response to the letter to the editors by Ottaiano et al.: "Cetuximab-dependent ADCC in cancer: Dream or reality?"

Cancer Immunology and Immunotherapy

相似文献

同项目论文

Cancer Immunology and Immunotherapy

相关期刊

检索历史清除